Investigates ozonation effect on sulfamethazine in UHT milk, suggesting a safe degradation method.
The presence of antibiotic residues in dairy products is a food safety and public health concern, due to their potential contribution to antimicrobial resistance and adverse health effects. This study investigated ozonation as an emerging non-thermal technology for the degradation of sulfamethazine (SMT) residues in ultra-high temperature (UHT) milk and evaluated its effects on selected physicochemical properties. Milk samples spiked with SMT at 50, 100, and 200 µg/L were treated with ozone of 6.19 mg/L for up to 60 min, while oxygen-treated samples were used as controls to distinguish ozone-mediated oxidation from effects associated with gas sparging. SMT concentrations were quantified by LC–MS/MS. Ozonation promoted a significant time-dependent decrease in SMT concentration ( p < 0.001), with reductions of 59.1, 63.1, and 53.6% after 60 min for initial concentrations of 50, 100, and 200 µg/L, respectively. In contrast, no significant SMT reduction was observed in oxygen-treated samples, supporting the interpretation that the observed decrease was specifically associated with O 3 exposure. Concentration-based kinetic modelling showed that first-order kinetics adequately described the degradation profiles of the ozonated treatments ( R 2 ≥ 0.991), with rate constants ranging from 0.0125 to 0.0162 min⁻ 1 and estimated half-lives from 42.8 to 55.5 min. Although statistically significant differences were detected in some treatment–time combinations, pH and total soluble solids (°Brix) showed only limited variations under the evaluated conditions. Instrumental color parameters also varied, with some ΔE values reaching potentially perceptible levels, but without a consistent progressive trend with ozone exposure time. Overall, ozonation promoted degradation of SMT while inducing limited or variable changes in the selected physicochemical parameters evaluated. However, studies addressing transformation-product identification, toxicity, and broader quality attributes are required before application in dairy processing.
No takes yet. Share an insight, caveat, or question.
Ribisse et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: